Cargando…
非小细胞肺癌不同部位组织样本PD-L1表达水平比较研究
BACKGROUND AND OBJECTIVE: The expression of programmed cell death ligand 1 (PD-L1) as a biomarker for immunotherapy in non-small cell lung cancer (NSCLC) is routinely detected in clinical pathology department. However, the spatial heterogeneity of PD-L1 expression in intrapulmonary tumors and extrap...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127754/ https://www.ncbi.nlm.nih.gov/pubmed/35570146 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.14 |